Presentations

Date	Title
May 21, 2021	May 2021 Corporate Presentation
May 5, 2021	Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome
May 5, 2021	Abstract 2739 Therapeutic Response to DCCR (Diazoxide Choline) Extended-Release Tablets in Patients with Prader-Willi Syndrome
May 5, 2021	A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Resting Energy Expenditure (REE) and Adiposity
May 4, 2021	Application of a semi-automated framework to characterize individual experiences with DCCR in Prader-Willi syndrome
April 14, 2021	Letter to PWS Community
February 4, 2021	Key Opinion Leader Meeting on DCCR for Treatment of Prader-Willi Syndrome
November 3, 2020	A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Body Composition and Adipokines
June 8, 2020	Soleno Therapeutics Phase III DESTINY PWS Trial Results
November 15, 2018	DCCR Fat Loss Poster Presentation at Obesity Society November 2018